publication venue for
- Frailty Among Patients With Acute ST-Elevation Myocardial Infarction in the United States: The Impact of the Primary Percutaneous Coronary Intervention on In-Hospital Outcomes. 34:E55-E64. 2022
- Dedicated Bifurcation Stents for Coronary Bifurcation Lesions: A Systematic Review and Meta-Analysis of Randomized-Controlled Trials.. 31:E344-E355. 2019
- Plaque Sealing With Drug-Eluting Stents Versus Medical Therapy for Treating Intermediate Non-Obstructive Saphenous Vein Graft Lesions: A Pooled Analysis of the VELETI and VELETI II Trials.. 31:E308-E315. 2019
- Ultrasound Guidance in Femoral Artery Catheterization: A Systematic Review and a Meta-Analysis of Randomized Controlled Trials.. 31:E192-E198. 2019
- Avoiding S3 Valve Over-Sizing by Deployment Balloon Over-Filling: Impact on Rates of Permanent Pacemaker and Other Procedural Complications During TAVR.. 30:23-27. 2018
- Comparison of Radial Access, Guided Femoral Access, and Non-Guided Femoral Access Among Women Undergoing Percutaneous Coronary Intervention.. 30:18-22. 2018
- Comparison of Drug-Eluting Stents With Bare-Metal Stents for PCI of Saphenous Vein Graft Lesions: Systematic Review and Meta-Analysis.. 28:E139-E169. 2016
- A Meta-Analysis of Randomized Controlled Trials of Conventional Stenting Versus Direct Stenting in Patients With Acute Myocardial Infarction. 27:404-410. 2015
- A Meta-Analysis of Randomized Controlled Trials of Conventional Stenting Versus Direct Stenting in Patients With Acute Myocardial Infarction.. 27:405-409. 2015
- Long-term benefit using DES in STEMI patients.. 23:342. 2011
- Left main thrombus as a complication of thrombectomy during primary percutaneous coronary intervention.. 23:E9-11. 2011
- Panel summary and recommendations on the role of thrombectomy with primary PCI for STEMI.. 22:34B-35B. 2010
- Selective strategy for thrombus management in STEMI interventions.. 22:26B-33B. 2010
- Myocardial salvage beyond recanalization of the STEMI lesion.. 21:456. 2009
- Early revascularization for cardiogenic shock in the elderly - has the moment of doubt passed?. 21:312-313. 2009
- IVUS-guided management of late stent malaposition with peri-stent restenosis with coronary artery aneurysm following drug-eluting stent implantation (paxlitaxel-eluting stent).. 21:E87-E90. 2009
- Focus: STEMI interventions. Heralding a new era in the management of STEMI interventions: optimizing the process and the procedure.. 20:A5-A6. 2008
- B-type natriuretic peptide and serum unbound free fatty acid levels after contemporary percutaneous coronary intervention.. 20:186-188. 2008
- Impact of routine in-hospital assessment of low-density lipoprotein levels and standardized orders on statin therapy in patients undergoing percutaneous coronary interventions.. 17:518-520. 2005
- Issues in the management of antiplatelet therapy in patients undergoing surgical revascularization. A roundtable discussion.. 17:283-287. 2005
- Bivalirudin, thrombin and platelets: clinical implications and future directions.. Suppl:2-15. 2003
- Aspirin and clopidogrel in patients with ACS undergoing PCI: CURE and PCI-CURE.. 15 Suppl B:17B-20B. 2003
- Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines.. 14 Suppl E:27E-34E. 2002
- Acute coronary syndromes: a focus on thrombin.. 14 Suppl B:2B-7B. 2002
- Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.. 12 Suppl F:14F-149. 2000
- Hemorrhagic complications in association with percutaneous coronary intervention: can the risk be attenuated?. 12 Suppl F:7F-13. 2000
- Putting heparin into perspective: its history and the evolution of its use during percutaneous coronary interventions.. 12 Suppl F:20F-206. 2000
- The mechanism of action of thrombin inhibitors.. 12 Suppl F:27F-232. 2000